The clinical characteristics of neuromyelitis optica spectrum disorders with other autoimmune diseases

The clinical characteristics of neuromyelitis optica spectrum disorders with other autoimmune diseases

Objective To investigate the clinical characteristics of neuromyelitis optica spectrum disorders (NMOSDs) with other autoimmune diseases. Methods and Results Retrospective analysis was performed on 55 NMOSDs patients admitted to Peking University Third Hospital from June 2014 to January 2019. There...

Full description

Bibliographic Details
Main Authors:	SUN Qing⁃li, MA Yan, FAN Dong⁃sheng
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2022-04-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:	neuromyelitis optica immune system diseases aquaporin 4
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/2489

Similar Items

Clinical and imaging characteristics and autoantibody analysis of neuromyelitis optica spectrum disorders
by: Nan LIU, et al.
Published: (2014-09-01)

Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders
by: A. N. Boyko, et al.
Published: (2021-10-01)

Association Between Helicobacter Pylori Infection and Seronegative Neuromyelitis Optica Spectrum Disorder
by: Mahdi Barzegar, et al.
Published: (2023-01-01)

The developmental history of study on neuromyelitis optica
by: Kai FENG, et al.
Published: (2014-09-01)

Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder
by: Oliver Schmetzer, et al.
Published: (2021-03-01)

Neuromyelitis optica spectrum disorder: a pediatric case report
by: Mujgan Arslan, et al.
Published: (2017-09-01)

Research progress of neuromyelitis optica spectrum disorders: Chinese scholars' reports published abroad
by: Jie-xi WEN, et al.
Published: (2016-09-01)

Clinical characteristics of late ⁃ onset and very late ⁃ onset neuromyelitis optica spectrum disorders
by: ZHANG Jing, et al.
Published: (2022-09-01)

Convergence spasm due to aquaporin-positive neuromyelitis optica spectrum disorder
by: Pınar Özçelik, et al.
Published: (2017-06-01)

Detection and clinical value of NMO-IgG in neuromyelitis optica
by: De-hui HUANG, et al.
Published: (2014-09-01)

Neuromyelitis optica spectrum disorder – case report
by: Grażyna Ściegienna-Zdeb, et al.
Published: (2016-04-01)

Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder
by: Vahid Shaygannejad, et al.
Published: (2021-01-01)

Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders
by: Leung-Wah Yick, et al.
Published: (2020-08-01)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
by: Narayanan Unni, et al.
Published: (2013-01-01)

Autoantibodies in patients with neuromyelitis optica
by: Xin FAN, et al.
Published: (2016-10-01)

Symptomatic narcolepsy as a presenting feature of neuromyelitis optica
by: Pradeep Kallollimath, et al.
Published: (2018-01-01)

Syndrome of inappropriate antidiuretic hormone secretion associated with seronegative neuromyelitis optica spectrum disorder
by: Shin Ju Oh, et al.
Published: (2017-03-01)

Neuromyelitis optica - an update: 2007-2009
by: Jacob Anu
Published: (2009-01-01)

Neuromyelitis optica spectrum disorders in pediatric patients
by: Yu. V. Tokareva, et al.
Published: (2018-04-01)

Neuromyelitis optica
by: Jacob Anu, et al.
Published: (2007-01-01)

Neuromyelitis optica spectrum disorders with an inverted V sign on spinal cord magnetic resonance imaging: antiaquaporin-4 antibody and functional vitamin B12 deficiency
by: Sung Jo Bang, et al.
Published: (2022-12-01)

Treatment of Neuromyelitis Optica Spectrum Disorders
by: Koon-Ho Chan, et al.
Published: (2021-08-01)

Late Onset of Neuromyelitis Optica Spectrum Disorders
by: Yara Dadalti Fragoso, et al.
Published: (2019-07-01)

The Association of Neuromyelitis Optica without Myelitis and Systemic Lupus Erythematosus: A Case Report
by: Asal Azami, et al.
Published: (2018-02-01)

Neuromyelitis Optica Spectrum Disorder Treatment—Current and Future Prospects
by: Marta Waliszewska-Prosół, et al.
Published: (2021-03-01)

Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
by: Edgar Carnero Contentti, et al.
Published: (2021-09-01)

Aquaporin-4 Gene Polymorphisms in Neuromyelitis Optica and Recurrent Optic Neuritis
by: Arman Çakar, et al.
Published: (2020-06-01)

Therapeutic efficacy of plasma exchange in neuromyelitis optica
by: Rajesh Kumar, et al.
Published: (2018-01-01)

Neuromyelitis Optica Spectrum Disorders: Clinical Perspectives, Molecular Mechanisms, and Treatments
by: Subramanian Thangaleela, et al.
Published: (2023-04-01)

Treatment response, risk of relapse and clinical characteristics of Taiwanese patients with neuromyelitis optica spectrum disorder
by: Yi-Hong Liu, et al.
Published: (2022-09-01)

Comments on the article “Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy”
by: A. N. Boyko
Published: (2023-02-01)

Intractable vomiting and hiccups as the presenting symptom of neuromyelitis optica
by: Girish Baburao Kulkarni, et al.
Published: (2014-01-01)

Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil
by: Thiago Gonçalves Fukuda, et al.
Published: (2022-03-01)

Predominant Myofibrillar Pathology with Preserved Sarcolemmal Aquaporin 4 Immunoreactivity in a Patient with Neuromyelitis Optica-Associated HyperCKemia
by: So-Young Huh, et al.
Published: (2021-12-01)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
by: Yang Ting-Ting, et al.
Published: (2016-01-01)

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01)

Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder
by: Byung Soo Kong, et al.
Published: (2017-09-01)

The distribution characteristics of aquaporin 4 antibody in patients with neuromyelitis optica and the relationship between aquaporin 4 antibody and oligoclonal bands
by: Hui-cong NIU, et al.
Published: (2014-09-01)

Primary Sjögren's syndrome patients with neuromyelitis optica spectrum disorders: clinical analysis of 4 cases and review of the literature
by: Jing-jiong CHEN, et al.
Published: (2013-05-01)

Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders
by: S. V. Kotov, et al.
Published: (2021-08-01)